Matches in Nanopublications for { ?s ?p "[These findings suggest that TMPRSS2-ERG with Edel is an aggressive and, in this study, uniformly lethal molecular subtype of prostate cancer associated with androgen-independent disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[These findings suggest that TMPRSS2-ERG with Edel is an aggressive and, in this study, uniformly lethal molecular subtype of prostate cancer associated with androgen-independent disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These findings suggest that TMPRSS2-ERG with Edel is an aggressive and, in this study, uniformly lethal molecular subtype of prostate cancer associated with androgen-independent disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These findings suggest that TMPRSS2-ERG with Edel is an aggressive and, in this study, uniformly lethal molecular subtype of prostate cancer associated with androgen-independent disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These findings suggest that TMPRSS2-ERG with Edel is an aggressive and, in this study, uniformly lethal molecular subtype of prostate cancer associated with androgen-independent disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP671254.RAShvV0A5C5WYybW35NS1EwviG-Rtqr18xIrMLFZeLKGg130_assertion description "[These findings suggest that TMPRSS2-ERG with Edel is an aggressive and, in this study, uniformly lethal molecular subtype of prostate cancer associated with androgen-independent disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671254.RAShvV0A5C5WYybW35NS1EwviG-Rtqr18xIrMLFZeLKGg130_provenance.
- NP671252.RAMEm-Y69oRXPYWeTIuQU27IuebNuOuTwQOKfmVYgBHOI130_assertion description "[These findings suggest that TMPRSS2-ERG with Edel is an aggressive and, in this study, uniformly lethal molecular subtype of prostate cancer associated with androgen-independent disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671252.RAMEm-Y69oRXPYWeTIuQU27IuebNuOuTwQOKfmVYgBHOI130_provenance.
- NP671255.RAz0EIpbj2f65Jf7WRql5nuoP8yavaiikLS-OzxY2K8pE130_assertion description "[These findings suggest that TMPRSS2-ERG with Edel is an aggressive and, in this study, uniformly lethal molecular subtype of prostate cancer associated with androgen-independent disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671255.RAz0EIpbj2f65Jf7WRql5nuoP8yavaiikLS-OzxY2K8pE130_provenance.
- NP671256.RA0h7-WfOjIDg91_Gp1xtw_7qeOvaxZQMYAOrX3gzkg3I130_assertion description "[These findings suggest that TMPRSS2-ERG with Edel is an aggressive and, in this study, uniformly lethal molecular subtype of prostate cancer associated with androgen-independent disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671256.RA0h7-WfOjIDg91_Gp1xtw_7qeOvaxZQMYAOrX3gzkg3I130_provenance.